Skip to content
Axcess News – Lifestyle
Author:
NEURIZON THERAPEUTICS LIMITED
HEALEY ALS Platform Trial Regimen I enrolment completed – Topline results for NUZ-001 accelerated to Q2 CY2027
July 17, 2026
HEALEY ALS Platform Trial Regimen I expands to 240 participants
May 27, 2026
Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial
March 6, 2026